Radiofrequency catheter ablation of @entity1165 in XXXX @entity67 / @entity296 using non-contact electroanatomical mapping: single-center experience with follow-up up to median of 30 months.

@entity1 @entity4128 @entity296 @entity1165 @entity1163 @entity67
OBJECTIVE OF STUDY: To evaluate the efficacy of radiofrequency ablation (RFA) of @entity1165 ( @entity1165 ) using non-contact electro-anatomic mapping in @entity1 with @entity4128 @entity67 / @entity296 ( @entity4128 /C). METHODS: Fifteen consecutive @entity1 (44    15 years) with @entity4128 /C and symptomatic VTs were studied. Eight @entity1 had @entity1163 . Two @entity1 had recurrent @entity1165 while on AICD; in three @entity1 , RFA was done prior to AICD implantation, and ten @entity1 refused AICD. After obtaining activation maps, first, the clinical @entity1165 was targeted, and then, other VTs were sought. RESULTS: Twenty-five inducible VTs were mapped, and 22 of them were successfully ablated. In 13 out of 15 @entity1 , all the clinical and inducible VTs were ablated. In two @entity1 , non-clinical inducible VTs could not be ablated. At 25    16 months (2-52 months), all @entity1 remained asymptomatic. Antiarrhythmic medications were discontinued after 6 months. Two @entity1 had recurrence of non-clinical @entity1165 on follow-up. There were no episodes of asymptomatic @entity1165 recorded in five @entity1 with AICD. CONCLUSION: A majority of induced @entity1165 in @entity1 with @entity4128 /C can be successfully mapped and ablated using the non-contact Ensite Array Mapping system with good long-term @entity1165 -free outcome. Ablation can be a useful adjunct to AICD implantation in such @entity1 .
